Skip to main content
. Author manuscript; available in PMC: 2018 Aug 13.
Published in final edited form as: Arq Neuropsiquiatr. 2016 Mar;74(3):244–252. doi: 10.1590/0004-282X20160038

Table 1.

Summary of main symptomatic treatment for patients with autosomal recessive hereditary ataxias.

Autosomal recessive ataxia Symptomatic treatment Level of evidence/
Grade of recommendation
Friedreich ataxia Idebenone 5–20 mg/kg day or CoQ10 30 mg/kg day Class I/A
Ataxia with vitamin E deficiency Vitamin E supplementation Class III/B
Abetalipropoteinemia Vitamin E supplementation 150 mg/kg; Vitamin A;
Medium-chain triglyceride supplement and/or low fat diet
Class IV/Good practice point
Refsum’s disease Diet modification to decrease intake of phytanic acid;
Plasmapheresis
Class IV/Good practice point
Niemann-Pick type C Miglustat Class III/B
Cerebrotendinous xanthomatosis Chenodeoxycholic acid 750 mg/day, HMG-CoaA reductors Class III/C
Ataxia associated with CoQ10 deficiency CoQ10 supplementation 30 mg/kg/day Class IV/Good practice point
Glutl deficiency syndrome Ketogenic diet Class III /C